$A News
Last published 1d ago
- 1d agoAAgilent Expands Tumor Profiling Portfolio with SureSelect Cancer Research Pan HemeBusiness WireSANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the SureSelect Cancer Research Pan Heme, a hybrid capture-based next-generation sequencing (NGS) research solution for comprehensive genomic profiling of hematologic malignancies. Developed in collaboration with experts at Roswell Park Comprehensive Cancer Center, the solution integrates DNA and RNA profiling ...
- 1w agoAAgilent to Announce Fourth-Quarter Fiscal Year 2026 Financial Results on Nov. 23Business WireAgilent Technologies Inc. (NYSE:A) will release financial results for the fourth quarter of fiscal year 2026 after the stock market closes on Monday, Nov. 23. The company will host a conference call to discuss the
- 2w agoAAgilent and University of Chicago Launch Center of Excellence for Energy Materials ResearchBusiness WireAgilent CoE supports research on next-generation energy storage materials Agilent Technologies Inc. (NYSE:A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of
- 4w agoAAgilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific IntelligenceBusiness WireAdvances Agilent’s position as a leading pathology solutions provider, with a unique and differentiated combination of instruments, reagents, and software Acquisition seamlessly builds on Agilent’s pathology
- 1mo agoAAgilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry WorkflowsBusiness WireAutomated platform helps laboratories simplify sample preparation and move seamlessly to data acquisition Agilent Technologies Inc. (NYSE:A) today announced the launch of the NovoStation Sample Preparation System, a
- 1mo agoAAgilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell ImagersBusiness WireSoftware module brings AI-based cell identification and segmentation to BioTek Gen5 imaging workflows Agilent Technologies Inc. (NYSE:A) today announced the launch of the Agilent BioTek Gen5 AI cell identification
- 1mo agoAAgilent Launches TapeStationDx Systems for Clinical NGS Sample Quality ControlBusiness WireNew CE-IVD-labeled systems and software bring established TapeStation technology to regulated clinical laboratory workflowsAgilent Technologies Inc. (NYSE:A) today announced the launch of the Agilent 4150 TapeStationDx
- 1mo agoACORRECTING and REPLACING Agilent Announces Cash Dividend of 25.5 Cents per ShareBusiness WireFirst paragraph, second sentence of release should read: The quarterly dividend will be paid on October 28, 2026, to all shareholders of record as of the close of business on October 6, 2026. (instead of The quarterly
- 1mo agoCTVAaCorteva Board of Directors Approves Vylor DistributionPR NewswireCorteva (NYSE: CTVA) today announced that its Board of Directors has approved the previously announced separation of Corteva into two independent,...
- 2mo agoAAgilent to Participate in J.P. Morgan U.S. All Stars ConferenceBusiness WireAgilent Technologies Inc. (NYSE:A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the J.P. Morgan U.S. All Stars Conference. The event is scheduled for 10 a.m.
- 2mo agoAAgilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of DirectorsBusiness WireAgilent Technologies Inc. (NYSE:A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of
- 2mo agoAAgilent Expands Digital Pathology Offering with U.S. Launch of the Agilent S540MD Slide Scanner SystemBusiness WireThe FDA-cleared system will strengthen Agilent's support for digital pathology laboratoriesAgilent Technologies Inc. (NYSE:A) today announced the U.S. launch of the Agilent S540MD Slide Scanner System, a whole slide
- 2mo agoAAgilent Introduces the Cary 635 FTIR SpectrometerBusiness WireA compact, user-friendly system designed for today’s laboratory demands Agilent Technologies, Inc. (NYSE:A) today announced the launch of the Agilent Cary 635 FTIR spectrometer, setting a new standard for compact,
- 2mo agoAAgilent Reports Third-Quarter Fiscal Year 2026 Financial ResultsBusiness WireDelivers strong Q3 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Third-quarter fiscal year 2026 Revenue of $1.88 billion for the third
- 3mo agoAAgilent Research Catalyst Award Presented to Eastern Institute of Technology, NingboBusiness WireEastern Institute of Technology professor recognized for advancing PFAS and emerging contaminant analysis Agilent Technologies Inc. (NYSE:A) today announced that the Eastern Institute of Technology, Ningbo has
- 3mo agoAAgilent to Announce Third-Quarter Fiscal Year 2026 Financial Results on Aug. 26Business WireAgilent Technologies Inc. (NYSE:A) will release financial results for the third quarter of fiscal year 2026 after the stock market closes on Wednesday, Aug. 26. The company will host a conference call to discuss the
- 3mo agoAAgilent Receives EU Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CarcinomaBusiness WireApproval expands PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab) Agilent Technologies Inc. (NYSE:A) today announced it has received European Union (EU) certification for PD-L1 IHC 22C3
- 4mo agoAAgilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal AdenocarcinomaBusiness WireTest enables identification of patients whose tumors express PD-L1 and who may be eligible for treatment with OPDIVO® (nivolumab) or OPDIVO QVANTIG® Agilent Technologies Inc. (NYSE:A) today announced that it has
- 4mo agoAAgilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic AnalysisBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to
- 4mo agoAAgilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSightBusiness WireSimplifying label-free imaging analysis for more confident real-time cell analysis Agilent Technologies Inc. (NYSE:A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module
- 4mo agoAExcellere Partners and GHO Capital complete sale of Biocare Medical to Agilent TechnologiesGlobeNewswireDenver, CO and London, UK – 25 June 2026: Excellere Partners ("Excellere"), a Denver-based private equity firm specializing in partnering with entrepreneurs and management teams, and GHO Capital Partners LLP
- 4mo agoAAgilent Completes Acquisition of Biocare MedicalBusiness WireHighly complementary combination expands Agilent’s pathology portfolio and ability to serve customers across clinical and research settingsExpected to be accretive to Agilent’s top-line growth rate, margin profile and
- 5mo agoAAgilent, OpenAI, BCG Collaborate to Accelerate Customer-Focused, AI-Driven Scientific InnovationBusiness WireAgilent Technologies Inc. (NYSE:A) today announced a collaboration with OpenAI and Boston Consulting Group (BCG) to accelerate the deployment of artificial intelligence (AI) across the company's products, operations,
- 5mo agoAAgilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction AdenocarcinomaBusiness WireApproval expands PD-L1 testing onto an automated workflow to support treatment decisions with KEYTRUDA® (pembrolizumab)¹,² Agilent Technologies Inc. (NYSE:A) today announced that the U.S. Food and Drug
- 5mo agoAAgilent Introduces OpenLab Sync to Support Guided, Digital Execution in the LaboratoryBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the introduction of OpenLab Sync, a new Lab Execution System (LES) that enables laboratories to digitally connect scientific workflows from method design through
- 5mo agoAQ2 2026 Agilent Technologies Inc. Earnings Conference Call - AGILENT TECHNOLOGIES INCEarnings Call TranscriptsLadies and gentlemen, thank you for joining us and welcome to the Q2 2026 Agilent Technologies Inc. Earnings Conference Call. After today's prepared remarks, we will host a question and answer session. If you would like
- 5mo agoAAgilent Reports Second-Quarter Fiscal Year 2026 Financial ResultsBusiness WireDelivers strong Q2 results and raises FY26 revenue growth, margin expansion, and non-GAAP EPS(4) guidance on continued operational momentum Second-quarter fiscal year 2026 Revenue of $1.83 billion for the second
- 5mo agoAAgilent Launches New GC Systems with GC Assist to Improve Laboratory Efficiency and Data QualityBusiness WireNew 8890B and 8860B gas chromatographs integrate intelligent monitoring and remote diagnostics Agilent Technologies Inc. (NYSE:A) today announced the launch of the new 8890B GC and 8860B GC with GC Assist. GC Assist
- 5mo agoATYO:1060Agilent Launches Multi-Attribute Method (MAM) Solution for BioPharma Quality ControlBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid
- 5mo agoAAgilent Unveils the 9500 ICP-MS: Redefining Trace Element AnalysisBusiness WireNext-generation ICP-MS/MS delivers faster measurements, simplified workflows, and easier access to advanced elemental analysis Agilent Technologies Inc. (NYSE:A) today announced the launch of the Agilent 9500 Triple
- 5mo agoAAgilent Launches 1290 Infinity III Fluorescence Detector for Confident Trace Analysis at UHPLC SpeedBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the launch of the Agilent 1290 Infinity III Fluorescence Detector (FLD), a new fluorescence detector designed specifically for modern ultra-high-performance liquid
- 5mo agoAAgilent Announces Cash Dividend of 25.5 Cents per ShareBusiness WireAgilent Technologies Inc. (NYSE:A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on July 22, 2026, to all shareholders of record as of the close of
- 5mo agoAAgilent to Supply Next Generation Alarm Resolution Technology to U.S. Airport Security Screening Checkpoints ahead of FIFA World Cup 2026Business WireAgilent has been awarded a contract by the Transportation Security Administration (TSA) to supply its Bulk Resolution Technology (BRT) systems to passenger security checkpoints at FIFA World Cup U.S. host city
- 6mo agoAAgilent to Participate in Jefferies Global Healthcare ConferenceBusiness WireAgilent Technologies Inc. (NYSE:A) today announced that CEO Padraig McDonnell and CFO Adam Elinoff will participate in a fireside chat at the Jefferies Global Healthcare Conference. The event is scheduled for 9:20 EDT
- 6mo agoAAgilent Names Michael Buckner as Chief Legal OfficerBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the appointment of Michael Buckner as chief legal officer, effective today. Buckner brings nearly three decades of experience as a senior global legal executive, with
- 6mo agoAAgilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27Business WireAgilent Technologies Inc. (NYSE:A) will release financial results for the second quarter of fiscal year 2026 after the stock market closes on Wednesday, May 27. The company will host a conference call to discuss the
- 7mo agoAAgilent Showcases Cancer Research Solutions at AACR 2026Business WireAgilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR)
- 7mo agoAAgilent Announces the BioTek Cytation 9 Cell Imaging Multimode ReaderBusiness WireAgilent Technologies, Inc. (NYSE:A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and
- 7mo agoAAgilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Esophageal or Gastroesophageal Junction (GEJ) CarcinomaBusiness WireTest enables identification of patients whose tumors express PD-L1 for potential treatment with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. (NYSE:A) today announced that it has received U.S. Food and
- 7mo agoAAgilent Showcases Advances in Precision Oncology and Digital Pathology at USCAP 2026Business WireExpanded PD‑L1 indication and end‑to‑end digital pathology workflows support modern pathology practice Agilent Technologies Inc. (NYSE:A) today announced it will feature its latest advances in precision oncology and
- 8mo agoAAgilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United StatesBusiness WireAgilent Technologies Inc. (NYSE:A) today announced the launch of Agilent Advanced Therapeutics, a unified Contract Development and Manufacturing Organization (CDMO) solution integrating the company's expanding
- 8mo agoAExcellere Partners and GHO Capital Sell Biocare Medical to Agilent TechnologiesGlobeNewswireAgilent to acquire Biocare in an all-cash transaction valued at $950 millionTransaction follows significant period of growth under Excellere Partners and GHO Capital stewardship, with annual double-digit revenue and
- 8mo agoAAgilent to Acquire Biocare Medical, a Global Leader in Clinical and Research Pathology SolutionsBusiness WireExpands Agilent's pathology portfolio through addition of highly complementary antibody, reagent and instrument business with annual double-digit revenue and profit growth since 2021 Expected to be accretive to
- 8mo agoAAgilent Reports First-Quarter Fiscal Year 2026 Financial ResultsBusiness WireDelivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS(3) guidance while confirming core-revenue growth(1) and margin expansion First-quarter fiscal year 2026 Revenue of $1.80
- 8mo agoAAgilent to Participate in TD Cowen's 46th Annual Health Care ConferenceBusiness WireAgilent Technologies Inc. (NYSE:A) today announced that Chief Financial Officer Adam Elinoff and Head of Investor Relations Tejas Savant will participate in a fireside chat at TD Cowen's 46th Annual Health Care
- 9mo agoAAgilent Announces Cash Dividend of 25.5 Cents per ShareBusiness WireAgilent Technologies Inc. (NYSE:A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on April 22, 2026, to all shareholders of record as of the close of
- 9mo agoAAgilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact AwardBusiness WireAward honors leadership in sustainable laboratory practices and circular economy advancement Agilent Technologies Inc. (NYSE:A) today announced that Boehringer Ingelheim has been selected as the winner of Agilent's
- 9mo agoAAgilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC)Business WireApproval expands first-line PD-L1 testing to support treatment decisions with KEYTRUDA® (pembrolizumab)1, 2 Agilent Technologies Inc. (NYSE:A) today announced that the U.S. Food and Drug Administration (FDA) has
- 9mo agoAAgilent Showcases Next‑Generation Automated Solutions at SLAS2026Business WireConnected with confidence to accelerate scientific discovery Agilent Technologies Inc. (NYSE:A) announced today that it will present a range of next‑generation automated workflow innovations at the SLAS2026
- 9mo agoAAgilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25Business WireAgilent Technologies Inc. (NYSE:A) will release financial results for the first quarter of fiscal year 2026 after the stock market closes on Wednesday, Feb. 25. The company will host a conference call to discuss the